On stage

Upcoming Events

November 9, 2020

DIA Real-World Evidence Conference

The selection and use of external comparators for expedited drug development
Jeremy Rassen
November 15, 2020

AI and Big Data in Cancer Conference

Building a digital medicine company
Dave Vavrasek
February 2, 2021

7th Annual LSX World Congress

Optimizing real-world evidence and real-world data
Carolyn Magill

Past Events

September 24, 2020

World Pharma Pricing and Market Access Congress

RWE for regulatory and HTA decision-making: latest precedent and what's ahead
Ashley Jaksa
September 17, 2020

Morgan Stanley Virtual Global Healthcare Conference

Fireside chat
Carolyn Magill
September 16, 2020

ICPE All Access

Multiple presentations
Aetion scientists
September 14, 2020

Virtual ISPOR Asia Pacific 2020

Access to personalized medicine: Challenges from single arm studies
Jeremy Rassen
August 6, 2020

Webinar with McDermott Will & Emery LLP

Evolving opportunities and challenges for real-world evidence and data-powered solutions
Carolyn Magill
August 5, 2020

HTAi 2020 Virtual Annual Meeting

What does good look like? Evaluating decision-grade RWE
Ashley Jaksa
June 25, 2020

PCMG Live

COVID-19: Forces innovation! Speeding up the pace of change
Jeremy Rassen
June 23, 2020

Webinar with HealthVerity

RWE and real-time insights: how to advance regulatory and commercial strategy in the COVID-19 era
Jeremy Rassen
June 17, 2020

DIA 2020 Virtual Global Annual Meeting

Combining multiple real-world data sources to maximize value
Jeremy Rassen
June 8, 2020

BIO Digital 2020

Financing transformative therapies: Cross-sector perspective on value and payment
Maya Tsukernik
June 4, 2020

HealthEconomics.com webinar

How to build a leading-practice RWE program to inform innovative drug contracting and market access
Carolyn Magill
May 29, 2020

DIA Biostatistics Industry and Regulator Forum

A community of networks: Creating and leveraging a network of distributed data supporting medical product development
Jeremy Rassen
May 19, 2020

Virtual ISPOR 2020

RWE guidance and frameworks: What elements are necessary to promote quality, transparency, and validity in real-world evidence
Nicolle Gatto
April 23, 2020

Informa webinar

Real-world evidence for regulatory decision-making
Jeremy Rassen & Sebastian Schneeweiss
April 16, 2020

WuXi Online Forum II on COVID-19

Harnessing our collective power
Carolyn Magill
April 2, 2020

eyeforpharma Barcelona Virtual 2020

Generate RWE pre-approval to inform regulatory decisions and expand access
Carolyn Magill
February 28, 2020

MIT Sloan Healthcare and BioInnovations Conference

Innovation showcase presentation
Liz Garry
February 12, 2020

RWE Leaders Forum

Guest speaker session
Carolyn Magill
February 10, 2020

BIO CEO & Investor Conference

Commercialization strategies for communicating evidence of a therapy’s value
Carolyn Magill
February 9, 2020

HBS 17th Annual Health Care Conference

Lunch roundtable
Christina Purpura
January 14, 2020

J.P. Morgan 38th Healthcare Conference

WuXi global forum: "The shifting paradigm: From sick care to health care"
Carolyn Magill
January 13, 2020

W2O's 6th Annual Digital Health Luncheon at J.P. Morgan

Healthcare's use of data and new data sources
Carolyn Magill
December 10, 2019

Digital Healthcare Innovation Summit

Building a strong case with real-world evidence
Carolyn Magill
December 10, 2019

HIMSS & Health 2.0 Japan 2019

Keynote: Using real-world evidence to answer critical questions in health care
Jeremy Rassen
December 9, 2019

Longwood Annual Healthcare Leaders Meeting

Getting to drug approval
Carolyn Magill
December 6, 2019

16th Global Cardiovascular Clinical Trialists Forum

Real-world data to predict randomized trial results before they’re done: The RCT DUPLICATE initiative
Nicolle Gatto
December 3, 2019

eyeforpharma Webinar

Let's talk about value: Use RWE to determine drug price and performance
Carolyn Magill
November 18, 2019

United States of Care 2019

Next generation challenges and opportunities in health care
Carolyn Magill
November 15, 2019

DIA Real World Evidence Conference

What's next: Real-world evidence in the development and access of novel therapeutics
Jeremy Rassen
November 12, 2019

Friends of Cancer Research Annual Meeting

Characterizing the use of external controls for augmenting randomized control arms and confirming benefit
Jeremy Rassen
November 6, 2019

ISPOR Europe 2019

Big healthcare data — Endless opportunities for research and learning
Jeremy Rassen
November 5, 2019

ISPOR Europe 2019

Are value assessment frameworks using RWE? A review of NICE and ICER psoriasis assessments
Ashley Jaksa
November 4, 2019

ISPOR Europe 2019

Are we there yet? Using RWD for regulatory-grade external control arms
Jeremy Rassen & Yin Ho
November 4, 2019

ISPOR Europe 2019

Themes in the design of pharmaceutical value-based contracts in the United States and Europe
Andrew Weckstein
November 4, 2019

ISPOR Europe 2019

Transparency in RWE — Time for a unified approach
Sebastian Schneeweiss
November 2, 2019

ISPOR Europe 2019

Use of propensity scores in observational studies of treatment effects
Jeremy Rassen
October 31, 2019

AMCP Nexus 2019

Using real-world evidence to design value-based contracts for the real world
Amanda Patrick
October 30, 2019

HLTH - The Future of Healthcare

The 7 things smart companies do to close the gender gap
Carolyn Magill
October 28, 2019

HLTH - The Future of Healthcare

Real-world evidence for value-based care
Carolyn Magill
October 24, 2019

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

Panel discussion: Pros & cons of real-world evidence framework by FDA. Perspective from different stakeholders — providers & payers
Kristen Coletto
October 18, 2019

2019 Wharton Health Care Conference on Artificial Intelligence

Real-world evidence case study
Carolyn Magill
October 16, 2019

Connected Health Conference

How real-world evidence will facilitate the shift toward value-based care
Wendy Turenne
October 11, 2019

ISPOR Summit 2019

Transparency in RWE — Time for a unified approach
Sebastian Schneeweiss
October 3, 2019

Duke-Margolis: Developing Real-World Data and Evidence to Support Regulatory Decision-Making

Methodological and analytical considerations for observational studies
Sebastian Schneeweiss
October 2, 2019

Future of Health

Digital Health 150
Jeremy Rassen

The Evidence Digest

Subscribe to our newsletter for insights and updates on real-world evidence research and applications.
Thank you, you've been subscribed.
Oops! Something went wrong while submitting the form.
©2020 Aetion, Inc.      Terms of Use      Privacy Policy      Patents